Last $26.19 USD
Change Today +0.07 / 0.27%
Volume 241.8K
IMS On Other Exchanges
Symbol
Exchange
New York
As of 4:15 PM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

ims health holdings inc (IMS) Snapshot

Open
$26.38
Previous Close
$26.12
Day High
$26.48
Day Low
$26.00
52 Week High
09/16/14 - $28.48
52 Week Low
04/15/14 - $21.63
Market Cap
8.7B
Average Volume 10 Days
372.6K
EPS TTM
--
Shares Outstanding
332.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMS HEALTH HOLDINGS INC (IMS)

ims health holdings inc (IMS) Related Bloomberg News

View More Bloomberg News

ims health holdings inc (IMS) Related Businessweek News

No Related Businessweek News Found

ims health holdings inc (IMS) Details

IMS Health Holdings, Inc. provides information, services, and technology to the healthcare industry worldwide. The company develops healthcare measurement solutions, such as IMS LifeLink program that provides data sourced from longitudinal prescriptions, medical claims, and electronic medical records; IMS NPA Market Dynamics, a national prescription audit program; IMS Xponent Prescribing Dynamics, a solution that allows clients to segment and identify physicians, refine messages, adapt and change tactics, and align sales compensation metrics; IMS PlanTrak Market Dynamics, which integrates with patient-level data providing payer and plan level visibility within key performance indicators separating new, switch, and repeat prescriptions; and Specialty Market Dynamics that integrates patient-level data from specialty pharmacy providers, retail pharmacies, and mail service suppliers to help clients in measuring, monitoring, and benchmarking specialty market performance. The company also provides consumer health insights, forecasting solutions, payer insights, pharmaceutical measurement solutions, and publications. In addition, it offers healthcare analytics and services that include specialty healthcare analytics, pharmaceutical R and D services, government solutions, business process outsourcing solutions, patient-centric solutions, pharmaceutical commercial services, and payer solutions; and consulting services. The company also serves pharmaceutical, payers, government, providers, pharmacies, consumer health, pharmaceutical distribution, and financial community sectors. IMS Health Incorporated has a strategic alliance with BroadReach Healthcare. The company was formerly known as Healthcare Technology Holdings, Inc. and changed its name to IMS Health Holdings, Inc. in December 2013. The company was founded in 1954 and is based in Danbury, Connecticut. The company is a former subsidiary of Nielsen Media Research, Inc.

9,500 Employees
Last Reported Date: 04/4/14
Founded in 1954

ims health holdings inc (IMS) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.4M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $412.5K
Senior Vice President of Supply Management
Total Annual Compensation: $402.0K
Senior Vice President of Strategy & Global Ph...
Total Annual Compensation: $400.3K
Senior Vice President of Global Technology & ...
Total Annual Compensation: $391.9K
Compensation as of Fiscal Year 2013.

ims health holdings inc (IMS) Key Developments

IMS Health Holdings, Inc. Presents at Leerink Partners Services Roundtable, Sep-30-2014 12:05 PM

IMS Health Holdings, Inc. Presents at Leerink Partners Services Roundtable, Sep-30-2014 12:05 PM. Venue: Le Parker Meridien Hotel, New York, New York, United States.

IMS Health Holdings, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Reaffirms Earnings Guidance for the Full Year 2014

IMS Health Holdings, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue of $662 million against $624 million a year ago. Operating loss was $39 million against operating income of $97 million a year ago. Loss before income taxes was $359 million against income before income taxes of $17 million a year ago. The second quarter 2014 net loss was $220 million, compared with net income of $8 million in last year's second quarter. The decline was due to several one-time charges relating to the company's IPO, including expenses of $219 million associated with the early termination and refinancing of debt, a $72 million payment to terminate the company's sponsor management services agreement, and a $30 million payment for the extinguishment of non-executive phantom stock grants that vested due to the IPO. Basic and diluted loss per share attributable to common shareholders was $0.67 against basic and diluted earnings per share attributable to common shareholders of $0.03 a year ago. Adjusted net income was $134 million, up 39.8% from $96 million in the prior year's quarter, due to the $20 million increase in adjusted EBITDA and a $25 million reduction in interest expense. Adjusted diluted earnings per share was $0.39 compared with $0.33 in the prior year period. Net cash used in operating activities was $126 million against net cash generated provided by operating activities of $126 million a year ago. Capital expenditures were $12 million against $10 million a year ago. Additions to computer software were $23 million against $18 million a year ago. Free cash outflow was $161 million against free cash inflow $98 million a year ago. For the six months, the company reported revenue of $1,307 million against $1,237 million a year ago. Operating income was $28 million against $176 million a year ago. Loss before income taxes was $396 million against income before income taxes of $34 million a year ago. Net loss was $244 million against net income of $20 million a year ago. Basic and diluted loss per share attributable to common shareholders was $0.80 against basic and diluted earnings per share attributable to common shareholders of $0.07 a year ago. Net debt declined $568 million due to the use of IPO proceeds and cash to reset the capital structure. Net cash used in operating activities was $229 million against net cash generated provided by operating activities of $124 million a year ago. Capital expenditures were $45 million against $17 million a year ago. Additions to computer software were $44 million against $17 million a year ago. Free cash outflow was $318 million against free cash inflow $76 million a year ago. For the full-year 2014, the company reaffirmed guidance for revenue growth of 5% to 6% and adjusted EBITDA growth of 7.5% to 9%. Adjusted Net Income is projected to grow 15% to 20%.

IMS Health Holdings, Inc. to Report Q2, 2014 Results on Jul 24, 2014

IMS Health Holdings, Inc. announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Jul 24, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMS:US $26.19 USD +0.07

IMS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Covance Inc $78.70 USD -1.79
PAREXEL International Corp $63.09 USD -0.98
Teradata Corp $41.92 USD +0.02
Verisk Analytics Inc $60.89 USD -0.04
Wolters Kluwer NV €21.12 EUR +0.01
View Industry Companies
 

Industry Analysis

IMS

Industry Average

Valuation IMS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book 5.1x
Price/Cash Flow 35.5x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS HEALTH HOLDINGS INC, please visit www.imshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.